Scarica l'app Stockscreener
2.21
0.45%
0.010
Dopo l'orario di chiusura:
2.22
0.01
+0.45%
Precedente Chiudi:
$2.20
Aprire:
$2.2
Volume 24 ore:
76,879
Relative Volume:
0.62
Capitalizzazione di mercato:
$115.57M
Reddito:
$14.18M
Utile/perdita netta:
$-82.66M
Rapporto P/E:
-1.70
EPS:
-1.3
Flusso di cassa netto:
$-50.80M
1 W Prestazione:
-4.33%
1M Prestazione:
+5.74%
6M Prestazione:
+11.62%
1 anno Prestazione:
+11.62%
Intervallo 1D:
$2.15
$2.28
Intervallo di 1 settimana:
$2.15
$2.38
Portata 52W:
$1.62
$2.625
Seer Inc Stock (SEER) Company Profile
Nome
Seer Inc
Settore
Industria
Telefono
650-453-0000
Indirizzo
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Confronta SEER con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.21 | 124.51M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-08-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2020-12-29 | Iniziato | BofA Securities | Neutral |
| 2020-12-29 | Iniziato | Cowen | Outperform |
| 2020-12-29 | Iniziato | JP Morgan | Overweight |
| 2020-12-29 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Seer Inc Borsa (SEER) Ultime notizie
Signal strength of Seer Inc. stock in tech scanners2025 Top Gainers & High Win Rate Trade Tips - newser.com
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025 - Investing News Network
Seer, Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 - Quiver Quantitative
RetinalGenix Technologies Contracts with Seer Bio to - GlobeNewswire
Does Seer Inc. stock trade at a discount to peersJuly 2025 Review & Low Risk High Win Rate Stock Picks - newser.com
Why Seer Inc. stock is seen as undervaluedWeekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Using Bollinger Bands to evaluate Seer Inc.CEO Change & Short-Term Trading Opportunity Alerts - newser.com
Will Seer Inc. price bounce be sustainableQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
Is Seer Inc. stock a smart buy before Fed meetingJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Can Seer Inc. stock hit record highs againWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics 2025 - Investing News Network
Seer to showcase proteomics platform at ASHG 2025 annual meeting By Investing.com - Investing.com Nigeria
Seer to showcase proteomics platform at ASHG 2025 annual meeting - Investing.com
Seer, Inc. to Showcase Proteomic Innovations at ASHG 2025 Annual Meeting - Quiver Quantitative
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025 - GlobeNewswire
CoLab Oct 16 — Seer’s Proteograph Drives Proteogenomic Insights at ASHG 2025 (Oct 14–18) - Stock Titan
What indicators show strength in Seer Inc.Share Buyback & High Accuracy Trade Alerts - newser.com
Seer's (SEER) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Smart tools for monitoring Seer Inc.’s price actionTrade Volume Summary & Growth Focused Entry Point Reports - newser.com
Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study With Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults - 富途牛牛
Using Ichimoku Cloud for Seer Inc. technicalsPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
Analyzing Seer Inc. with risk reward ratio charts2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
What analysts say about Seer Inc stockInstitutional Buying Trends & Superior Trading Ideas - earlytimes.in
Seer Inc Azioni (SEER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Seer Inc Azioni (SEER) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):